Bullet flag-united-kingdom flag-ireland

THIS WEBSITE IS INTENDED FOR HEALTHCARE PROFESSIONALS IN THE UK & IRELAND*

ENGAGE: Medical Education

We are delighted to welcome you to our ENGAGE platform, which aims to provide high quality, non-promotional scientific education on key topics across our portfolio.

Please feel free to browse through all our upcoming events, or filter based on your field of interest, and register for any topics of interest. We are also pleased to offer on-demand content for past events.

Upcoming Webinars

Innovative models for nurse/pharmacist involvement in respiratory care (with live Q&A)

  • Respiratory

28th September 2022 , 1-2pm

Presented by: Gillian Cameron & Lorraine Phillips

Successful innovations often possess two key qualities: they are both usable and desirable. One important area the NHS seeks improvement on, is adopting the role of respiratory nurses and pharmacists to modern patient’s and NHS needs. Chiesi has therefore invited two such healthcare professionals, Gillian Cameron and Lorraine Phillips, to share their expertise and innovative practices leading to a different way of providing patient care, as well as participate in a live Q&A to answer any questions that you may have.

On Demand Webinars

  • Respiratory

Virtual Asthma and COPD Review Pre and Post Pandemic

Presented by: Dr Phyllis Murphie

Virtual consultations now form an important part of normal everyday clinical practice, however there are still many outstanding questions as to how to achieve optimal patient care. In this webinar, Dr Phyllis Murphie shares her perspective on what to look out for both during and after virtual consultations.

  • Respiratory

The Management of COPD and Co-morbidities in a Post-COVID Environment

Presented by: Professor John Hurst

Professor Hurst discusses the impact of COVID-19 on COPD patients, associated co-morbidities, and recommendations for managing COPD in a post-COVID environment.

  • Respiratory

Asthma Diagnosis and Management of Associated Co-morbidities

Presented by: Professor Dominick Shaw

Professor Shaw discusses asthma care and the management of associated co-morbidities in the post-COVID environment.

  • Respiratory

Shared Decision Making in Secondary Care

Presented by: Dr Ernie Wong

Dr Wong discusses shared decision making in secondary care, its impact on patient care and outcomes as well as challenges in its implementation.

  • Respiratory

Shared Decision Making in Community Care

Presented by: Miss Joanne King

Miss King discusses shared decision making in community care, how to use decision aids in clinical practice and the benefits of this for patient care and outcomes.

  • Respiratory

Environmental Impact of SABA Overuse

Presented by: Professor Jennifer Quint

Professor Jennifer Quint discusses the environmental impact of poorly controlled respiratory patients and the findings of the SABINA clinical trials.

  • Respiratory

Opportunities for Minimising the Environmental Impact Across the Entire Inhaler Lifecycle

Presented by: Dr Anna Murphy

Dr Anna Murphy discusses the current inhaler policies and considerations to reduce the carbon footprint across the entire inhaler lifecycle.

  • Respiratory

Inhaler Switching Approaches in Asthma and COPD: What Factors to Consider?

Presented by: Professor Omar Usmani

Professor Usmani discusses the different switching approaches used to replace pMDI with DPI inhalers and their consequences on patient care.

  • Respiratory

Implementation of Inhaler Switching Approaches in Primary Care for Asthma and COPD

Presented by: Dr Andy Whittamore

Dr Andy Whittamore discusses how inhaler devices can be switched effectively in primary care, ensuring the right device is chosen for the right patient.

  • Cystic Fibrosis

Cystic Fibrosis, Clinical Trials & COVID-19

Presented by: Dr Damian Downey

Analysis of COVID-19 and its impact on cystic fibrosis studies. Updates on Therapeutics Development Network data in this regards and a summary of COVID-19 Antibody Response in Cystic Fibrosis study.

  • Cystic Fibrosis

Viral Infections in Cystic Fibrosis

Presented by: Dr Anirban Maitra

An overview of the importance of viral infections in on cystic fibrosis morbidity, the reasons for viral infections in patients with cystic fibrosis.

  • Respiratory

What does Inhaler Resistance Actually Mean?

Presented by: Mr David Harris

Mr David Harris explains in easy terms the key processes within a device during inhalation, like inhaler resistance and pressure drop.

  • Respiratory

What is the Clinical Relevance of Inhaler Resistance?

Presented by: Dr Toby Capstick

Dr Toby Capstick explains lung physiology, inspirational flow, and shares his extensive knowledge on inhaler devices to guide you in finding the right device for the right patient.

  • Respiratory

Treatable Traits in Asthma

Presented by: Dr Dhananjay Desai

Dr Dhananjay Desai talks about the concept of treatable traits and how these can be identified using biomarkers in patients with asthma.

  • Respiratory

Patient Centricity and Treatable Traits

Presented by: Ms Vikki Knowles

Ms Vikki Knowles champions the importance of a patient centric care approach and identifying treatable traits to improve asthma management.

  • Respiratory

Small Airway Disease in Asthma

Presented by: Dr Richard Russell

Dr Richard Russell describes the importance of small airway disease in asthma as well as its diagnosis and impact on patients’ overall disease phenotype.

  • Respiratory

Integrated care systems & Multi-Disciplinary Team (MDT) working

Presented by: Dr Deepak Subramanian

Dr Deepak Subramanian talks about how the respiratory integrated service (ImpACT+) has been successfully established in South Derbyshire and Erewash.

  • Respiratory

Integrated Care from Rhetoric to Reality: Why, What, How?

Presented by: Dr Binita Kane

Dr Binita Kane introduces the concept of integrated care, explores why it is needed and how it can benefit patients and working practice alike.

  • Respiratory

Diagnostics in Asthma – Making a Correct Diagnosis

Presented by: Professor Andrew Menzies-Gow

Professor Menzies-Gow addresses challenges in making a correct asthma diagnosis, considers endotypes and the use of biomarkers towards precision medicine.

  • Respiratory

Diagnosing Asthma – Clinical Tests Revisited

Presented by: Ms Samantha Prigmore

Ms Samantha Prigmore revisits common respiratory tests to diagnose asthma and provides her perspective as to how best to utilise these tests.

  • Respiratory

Understanding Breathlessness in Asthma

Presented by: Professor Stephen Fowler

Professor Fowler explores potential causes of breathlessness by focussing on complex breathing patterns, caused by asthma or other diseases/conditions.

  • Respiratory

Inducible Laryngeal Obstruction: Chameleon Conundrums

Presented by: Dr Jemma Haines

Dr Haines describes Inducible Laryngeal Obstruction (ILO), gives examples how this condition may present in patients and explores how it can be managed.

  • Respiratory
  • Sustainability

Medicines Management Approach to the Environment

Presented by: Dr Anna Murphy

Dr Anna Murphy’s talk focusses on optimising medicines management of respiratory care, to the benefit of both patient outcomes as well as the environment.

  • Respiratory
  • Sustainability

Introduction to Global Heating and Ways to Benefit the Environment

Presented by: Dr Matt Sawyer

Dr Matt Sawyer explains global warming, the impact of F-gases within the NHS and maps out ways towards an environmentally friendly surgery.

  • Respiratory
  • Sustainability

Importance of Choosing the Right Device for the Right Patient

Presented by: Dr Azhar Saleem

Dr Azhar Saleem explores inhaler choices and shared decision making, using practical approaches to achieve improved asthma control and sustainability.

  • Respiratory
  • Sustainability

Practical Advice Around Inhaler Recycling

Presented by: Ms Carol Stonham

Ms Carol Stonham discusses inhaler recycling in her talk, touching on issues with recycling, PCRS advice and suggests ways to engage and motivate patients.

  • Respiratory
  • Sustainability

Introduction to Global Warming

Presented by: Jane Scullion

Ms Scullion explains the effects of global warming, the impact of F-Gases, and how inhalers contribute towards carbon emissions.

  • Respiratory
  • Sustainability

Patient-Centred Approach to Environmental Issues in Respiratory Care

Presented by: Dr Steve Holmes

Dr Holmes focuses on strategies to balance sustainability with patient-centred care. He discusses aspirations to reduce carbon footprint in the NHS.

  • Respiratory
  • Sustainability

High SABA Use: A Sign of the Uncontrolled Asthma Patient?

Presented by: Professor Jennifer Quint

Professor Quint discusses the high use of short-acting beta agonists (SABA) and asthma control, in the context of the global and UK SABINA findings.

  • Respiratory
  • Sustainability

The Greenest Inhaler is the One a Patient Can and Will Use

Presented by: Dr Toby Capstick

Dr Capstick is building on day-to-day practical advice for on how to balance patients disease control and environmental friendly aspirations.

  • COVID-19
  • Cystic Fibrosis

Impact of COVID-19 on Cystic Fibrosis Clinical Trials

Presented by: Dr Damian Downey

A presentation on the impact of COVID-19 on Cystic Fibrosis clinical trials, sponsors, participants, regulatory requirements, changing practice and research sites.

  • COVID-19

Emerging Therapies for COVID-19

Presented by: Professor Dave Singh

Professor Dave Singh summarises the pathology of COVID-19, and data published from clinical trials up to June 2020.

  • COVID-19
  • Respiratory

Airways Management in the COVID-19 Patient – Can Proning Help?

Presented by: Dr Omar Usmani and Dr Suveer Singh

Dr Usmani and Dr Singh discuss the management of airways disease in patients with COVID-19, and explore the role of proning outside of the ITU setting.

  • COVID-19

COVID-19 and Immune Responses

Presented by: Professor Sebastian Johnston

Prof Johnston explains the impact of population level interventions such as lockdowns on mortality and innate immune responses to COVID-19 infection.

  • COVID-19
  • Respiratory

Escalation and Ventilation Strategies for COVID-19 Patients

Presented by: Dr Rachel Kaminski and Professor Joerg Steier

A summary of escalation and ventilation strategies for COVID-19 patients based on personal experiences and published evidence.

  • Respiratory

Understanding How Biomarkers Can Improve Asthma Care

Presented by: Dr David Jackson

A discussion on the relevance of blood eosinophils and FeNO as biomarkers in asthma.

  • Respiratory

The Importance of Small Airways Disease in Asthma

Presented by: Professor Salman Siddiqui

Presentation of data from the ATLANTIS study, exploring the results of various diagnostic tools on detecting small airways disease in asthmatic patients.

  • Respiratory

Perceptions and Challenges to Adherence in Asthma

Presented by: Dr Anna Murphy

Dr Anna Murphy discusses patient barriers to inhaler adherence and how to address these with personalised care, shared decision making and health coaching.

  • Respiratory

Ensuring High Quality Asthma Reviews in a Virtual Consultation

Presented by: Natalie Harper

Summary of key elements for telephone and video consultations, including basic legal/confidentiality considerations, and personal wellbeing.

  • Neonatology

Late Preterm and Early Term: Bigger Babies Have Challenges Too

Presented by: Professor Elaine Boyle

A summary of outcomes and implications for clinical practice for more mature early term and term preterm babies.

  • Neonatology

How Can Cord Management Enhance Physiological Newborn Transition?

Presented by: Professor Heike Rabe

Definitions of optimal cord management methods, resuscitation versus physiological transition, and the benefits of optimal cord management in term babies.

  • Cystic Fibrosis

Results of the Cystic Fibrosis HealthHub Trial

Presented by: Dr Martin Wildman

Overview of the CF HealthHub program with the aim of helping build habits and develop adherence to treatments in Cystic Fibrosis patients.

  • Cystic Fibrosis

Difficult Diagnosis in Adult Cystic Fibrosis Patients

Presented by: Dr Nicholas Simmonds

Overview of wide spectrum of Cystic Fibrosis and its impact on the ability to diagnose along with the value of nasal potential difference to diagnostic process.

  • Cystic Fibrosis

Transitional Care in Cystic Fibrosis

Presented by: Louise Wooldridge

A presentation on the need for transitioning of adolescents with Cystic Fibrosis to move from child-focused care to adult oriented health care.

  • COVID-19
  • Cystic Fibrosis

Digital Innovation in Cystic Fibrosis Care

Presented by: Dr Sue Madge

A look into the digital innovations in Cystic Fibrosis care, and the impact of COVID-19. Answers to why? what? and how the digital innovations have been done.

  • COVID-19
  • Cystic Fibrosis

Cystic Fibrosis Transplant Care During and After COVID-19

Presented by: Dr Vicky Gerovasili

The UK and international data on the impact of COVID-19 on lung transplant mortality, post-transplant care and pre-transplant referral assessment pathway.

  • COVID-19
  • Cystic Fibrosis

Feelings and Fears in Adults With and Without Cystic Fibrosis

Presented by: Professor Carlo Castellani

An overview of clinical studies, and a summary of data from a questionnaire which looked at the implications of COVID-19 in both CF and non-CF patients.

  • COVID-19
  • Cystic Fibrosis

Cystic Fibrosis: Overcoming the Challenge of Providing Physio

Presented by: Ms Lisa Morrison

Reviewing the way physiotherapists work to tackle the complications of providing physiotherapy during the COVID-19 crisis whilst keeping patients safe.

  • COVID-19
  • Cystic Fibrosis

Shielding in Cystic Fibrosis, A Psychological Perspective

Presented by: Dr Mandy Bryon

A look into the psychological implications of shielding during the COVID-19 pandemic, plus ways in which the psychological burden could be reduced.

  • COVID-19
  • Cystic Fibrosis

Shielding in Cystic Fibrosis, A Physical Health Perspective

Presented by: Dr Carsten Schwarz

An overview of the health perspectives of COVID-19 in Cystic Fibrosis patients during the first wave of pandemic.